Suffocation in asthma and COVID-19: Supplementation of inhaled corticosteroids with alkaline hydrogen peroxide as an alternative to ECMO
Authors:
- Aleksandr UrakovAUAleksandr Urakov
- Natalya UrakovaNUNatalya Urakova
- Petr ShabanovPSPetr Shabanov
- Roman RozovRRRoman Rozov
- Anatoly OsipovAOAnatoly Osipov
- Aleksandr SamorodovASAleksandr Samorodov
- Ilnur YagudinIYIlnur Yagudin
- Darya SuntsovaDSDarya Suntsova
- Nikita MuhundinovNMNikita Muhundinov
- Anastasia StolyarenkoASAnastasia Stolyarenko
Preprint
- 11 July 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Suffocation syndrome is the leading cause of hypoxia and mortality in the most common lung diseases, asthma and COVID-19. Inhaled corticosteroids (ICSs) have been shown to be the main-stay of critical care in these diseases. Meanwhile, mortality from strangulated hypoxia is highest in low-income countries because ICSs are not currently available to many patients. Warm alkaline hydrogen peroxide solutions (WAHPSs) have reportedly been invented in recent years to urgently turn thick sputum, mucus, pus, serous fluid, blood clots and many other biological masses con-taining the enzyme catalase into a fluffy oxygenated foam. It has been shown that the mechanism of action of WAHPSs consists in alkaline saponification of lipid and protein-lipid complexes of bi-ological masses and their transformation into oxygen foam, because hydrogen peroxide is urgently decomposed into water and oxygen gas under the action of the biological masses catalase enzyme At that excess oxygen is absorbed into blood through lungs and increases blood oxygen saturation. Based on the described mechanism of action of WAHPSs and the high availability of their ingre-dients, it is suggested that mortality from choking and hypoxia in asthma and COVID-19 can be reduced by combining ICSs with inhaled WAHPSs, especially in poor countries. The essence of the inventions underlying the formation of WAHPSs is given.Keywords
All Related Versions
This publication has 153 references indexed in Scilit:
- Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidenceCochrane Database of Systematic Reviews, 2022
- Narrative Review of the Mechanisms and Treatment of Cough in Asthma, Cough Variant Asthma, and Non-asthmatic Eosinophilic BronchitisLung, 2022
- Inhaled corticosteroids for the treatment of COVID-19Cochrane Database of Systematic Reviews, 2022
- Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse eventsCochrane Database of Systematic Reviews, 2021
- Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19Intensive Care Medicine, 2021
- Effects of the Lower Airway Secretions on Airway Opening Pressures and Suction Pressures in Critically Ill COVID-19 Patients: A Computational SimulationAnnals of Biomedical Engineering, 2020
- Inside the lungs of COVID-19 diseaseInternational journal of legal medicine, 2020
- Dexamethasone or prednisolone for asthma exacerbations in children: A cost‐effectiveness analysisPediatric Pulmonology, 2020
- Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthmaCochrane Database of Systematic Reviews, 2020
- Lifestyle Changes and Childhood AsthmaIndian Journal of Pediatrics, 2012